Notice for tovorafenib (Ipsen Pty Ltd)
Active ingredients
tovorafenib
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
oral powder for suspension; film coated tablet
Indication
For the treatment of glioma
Therapeutic area
Oncology